HAP Trading’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30
Closed -$21K 1224
2022
Q4
$21K Sell
30
-5
-14% -$6.29K ﹤0.01% 945
2022
Q3
$24K Sell
35
-5
-13% -$6.61K ﹤0.01% 1148
2022
Q2
$32K Buy
40
+9
+29% +$9.26K ﹤0.01% 1200
2022
Q1
$20K Sell
31
-3
-9% -$4.05K ﹤0.01% 1560
2021
Q4
$45K Buy
34
+7
+26% +$18.7K ﹤0.01% 1523
2021
Q3
$18K Sell
27
-28
-51% -$97.9K ﹤0.01% 1830
2021
Q2
$74K Sell
55
-28
-34% -$111K ﹤0.01% 1329
2021
Q1
$131K Buy
+83
New +$468K 0.01% 872

Other funds holding BNGO

HAP Trading's BNGO Position: Q3 2021 in Review

HAP Trading sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 77 shares — an estimated $269K sold.

HAP Trading first reported a position in BNGO in Q1 2021 and held it in 2 quarters. The position peaked at $486K in Q1 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

  • HAP Trading reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
  • HAP Trading sold 77 Bionano Genomics shares in Q3 2021, an estimated $269K.
  • HAP Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 2 quarters.
  • HAP Trading's Bionano Genomics position peaked at $486K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.